Vanguard Group Inc Hoth Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.36 - $9.25 $63,957 - $1.64 Million
177,659 Added 23.23%
942,305 $328,000
Q1 2022

May 13, 2022
BUY
$0.52 - $1.3 $28,392 - $70,980
54,600 Added 7.69%
764,646 $529,000
Q3 2021

Nov 12, 2021
BUY
$1.15 - $1.62 $4,428 - $6,238
3,851 Added 0.55%
710,046 $845,000
Q2 2021

Aug 13, 2021
BUY
$1.31 - $2.14 $925,115 - $1.51 Million
706,195 New
706,195 $1.13 Million

Others Institutions Holding HOTH

# of Institutions
2
Shares Held
6K
Call Options Held
0
Put Options Held
0
View Full List

About Hoth Therapeutics, Inc.

HOTH Quotes by TradingView
  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email